SPL COMPONENTS LIMITED

Financial Health Score: B

Explanation: SPL Components Limited exhibits the robust constitution of a mature business, with a strong equity base and a decade of consistent net asset growth. However, this solid "skeletal structure" is currently experiencing acute "dehydration"—its cash reserves have drained to near zero. While the company is fundamentally solvent and profitable, this severe liquidity symptom requires immediate emergency care to prevent a short-term cash flow crisis.

1. Key Vital Signs

• Net Assets (Equity): £2,369,478 (2025)
  • Interpretation: Excellent. This is the company's "muscle mass." It has grown steadily from £753k in 2016 to over £2.3M in 2025. The business has been consistently building its retained earnings, indicating long-term financial health and resilience.
• Cash at Bank: £242 (2025) vs. £191,131 (2024)
  • Interpretation: Critical Warning. This is a severe drop in blood pressure. Cash has plummeted by over 99.8% in a single year. A business with over £4.5M in current assets but only £242 in the bank is operating on the absolute edge of a liquidity crisis.
• Current Assets vs. Current Liabilities: £4.57M vs. £2.44M
  • Interpretation: Healthy on paper. The current ratio is roughly 1.87, which is a normal, healthy reading. However, the "cholesterol" in the veins is high—£2.08M is tied up in stock, and £2.48M is owed by debtors.
• Profitability: £95,415 (2025 P&L Reserve Increase)
  • Interpretation: Recovering. The business returned to profit in 2025 after posting a loss of roughly £63k in 2024. The "diet" has improved, but the profit margins are relatively slim for a company of this size.
• Long-term Debt: £678 (2025)
  • Interpretation: Very Healthy. The company has virtually no long-term debt hanging over it, meaning it is not suffocating under interest payments or restrictive covenants.

2. Diagnosis

Chronic Solvency with Acute Illiquidity

The financial data reveals a business with a strong underlying constitution but suffering from a sudden, severe cash flow blockage.

The good news is that the company has dramatically reduced its short-term creditors (amounts falling due within one year dropped from £3.01M to £2.44M). They have successfully paid down substantial short-term debts. However, the way they achieved this is concerning: they essentially drained their lifeblood (cash) and relied heavily on collecting money from debtors to stay afloat.

With only £242 in the bank, the company is highly vulnerable to any disruption in its "circulatory system." If a major customer delays payment, or if stock fails to sell, the business will quickly run out of the oxygen (cash) it needs to meet its day-to-day payroll and operating expenses. The company is asset-rich but cash-poor, a classic symptom of over-trading or poor working capital management.

3. Recommendations

1. Emergency Cash Resuscitation: The immediate priority is to stabilize the cash position. The directors should explore short-term financing options, such as an overdraft facility or invoice discounting, to provide an immediate cash transfusion and ensure payroll and essential suppliers can be paid without disruption.
2. Improve Debtor "Circulation": With £2.48M tied up in debtors, tightening credit control is essential. Implement stricter payment terms, offer early payment discounts to customers, and aggressively chase overdue invoices. Getting money flowing through the veins faster is critical.
3. Reduce Stock "Cholesterol": At over £2M, stock levels are high. The business needs to assess whether this inventory is turning over efficiently or becoming stagnant. Liquidating slow-moving stock at a discount could provide a quick, healthy injection of cash.
4. Monitor the Heartbeat Weekly: With such a thin cash margin, the directors cannot afford to look at the numbers just once a year. Implement a rolling 13-week cash flow forecast to anticipate any future arrhythmias in cash flow before they become critical.